Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 2

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 2
---
 free cash flow growth thanks to our business strategy and the unique attributes of our portfolio. Below are just a few of the financial highlights of fiscal 2025 that tie both directly and indirectly into incentive program compensation.

| Top Line Trends•Revenue of$1,138M•Organic revenue growth of1.2%•Continued strong growth inInternational OTC segment | EPS•Adjusted Diluted EPS of$4.52•Adjusted EPS growth of7.3%•Strong financial profile leadingtosustained profitability | Free Cash Flow & Allocation•Free Cash Flow ofapproximately$243M•Reduced debt to lowest levelin Company history, enablingvalue-creating capital allocation |

Please refer to Appendix A for a reconciliation of non-GAAP organic revenue growth, Adjusted Diluted EPS and Free Cash Flow to our most directly comparable financial measures presented in accordance with GAAP. TOTAL REVENUES (In Millions)

ADJUSTED NET INCOME PER SHARE-DILUTED*

ADJUSTED FREE CASH FLOW** (In Millions)

* Adjusted net income per share-diluted is a non-GAAP financial measure and is reconciled to the reported GAAP figure in Appendix A and Exhibit 99.1 and 99.2 accompanying our earnings release filed with the Securities and Exchange Commission on May 8, 2025. ** Adjusted free cash flow is a non -GAAP financial measure. Management believes free cash flow is a commonly used measure of liquidity, indicative of cash available for debt repayment and acquisitions. Adjusted free cash flow is reconciled to GAAP Net Cash provided by operating activities in Appendix A and Exhibit 99.1 and 99.2 accompanying our earnings release filed with the Securities and Exchange Commission on May 8, 2025. Management believes that these measures provide additional ways to view our operations and a more complete understanding of our business than could be obtained absent this disclosure, when considered with both our GAAP results and our reconciliation thereto.

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     | 7 |

Company Highlights

Corporate Responsibility Prestige Consumer Healthcare’s Board of Directors, management and employees all recognize the responsibility that comes with selling trusted consumer healthcare brands, and the importance of integrating corporate responsibility into our operations and culture for the benefit of future generations. We are committed to building environmental sustainability, social responsibility, and effective corporate governance into all aspects of our business. We view this as sound business strategy that drives resiliency and long-term value creation for the benefit